Safety, Absolute Bioavailability, and Dose Proportionality of BMS‐181885 (I), A Novel 5HT1, Agonist, Following Intranasal (IN) Dosing in Humans

@article{Srinivas1999SafetyAB,
  title={Safety, Absolute Bioavailability, and Dose Proportionality of BMS‐181885 (I), A Novel 5HT1, Agonist, Following Intranasal (IN) Dosing in Humans},
  author={N. Srinivas and W. Shyu and S. Chang and I. Ferreira and D. Greene},
  journal={Clinical Pharmacology & Therapeutics},
  year={1999},
  volume={65}
}
Clinical Pharmacology & Therapeutics (1999) 65, 130–130; doi: